These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


148 related items for PubMed ID: 16178724

  • 21. Virally encoded chemokine binding proteins.
    Webb LM, Alcami A.
    Mini Rev Med Chem; 2005 Sep; 5(9):833-48. PubMed ID: 16178725
    [Abstract] [Full Text] [Related]

  • 22. An apparent paradox: chemokine receptor agonists can be used for anti-inflammatory therapy.
    Ali S, O'Boyle G, Mellor P, Kirby JA.
    Mol Immunol; 2007 Mar; 44(7):1477-82. PubMed ID: 17000001
    [Abstract] [Full Text] [Related]

  • 23. Broad-spectrum chemokine inhibition ameliorates experimental obliterative bronchiolitis.
    Naidu BV, Farivar AS, Krishnadasan B, Woolley SM, Grainger DJ, Verrier ED, Mulligan MS.
    Ann Thorac Surg; 2003 Apr; 75(4):1118-22. PubMed ID: 12683548
    [Abstract] [Full Text] [Related]

  • 24. Touch of chemokines.
    Blanchet X, Langer M, Weber C, Koenen RR, von Hundelshausen P.
    Front Immunol; 2012 Apr; 3():175. PubMed ID: 22807925
    [Abstract] [Full Text] [Related]

  • 25. Macrophage Migration Inhibitory Factor (MIF)-Based Therapeutic Concepts in Atherosclerosis and Inflammation.
    Sinitski D, Kontos C, Krammer C, Asare Y, Kapurniotu A, Bernhagen J.
    Thromb Haemost; 2019 Apr; 119(4):553-566. PubMed ID: 30716779
    [Abstract] [Full Text] [Related]

  • 26. Engineering broad-spectrum inhibitors of inflammatory chemokines from subclass A3 tick evasins.
    Devkota SR, Aryal P, Pokhrel R, Jiao W, Perry A, Panjikar S, Payne RJ, Wilce MCJ, Bhusal RP, Stone MJ.
    Nat Commun; 2023 Jul 14; 14(1):4204. PubMed ID: 37452046
    [Abstract] [Full Text] [Related]

  • 27. Chemokines, chemokine receptors and small-molecule antagonists: recent developments.
    Onuffer JJ, Horuk R.
    Trends Pharmacol Sci; 2002 Oct 14; 23(10):459-67. PubMed ID: 12368070
    [Abstract] [Full Text] [Related]

  • 28. Chemokines and chemokine receptors blockers as new drugs for the treatment of chronic obstructive pulmonary disease.
    Caramori G, Di Stefano A, Casolari P, Kirkham PA, Padovani A, Chung KF, Papi A, Adcock IM.
    Curr Med Chem; 2013 Oct 14; 20(35):4317-49. PubMed ID: 24059236
    [Abstract] [Full Text] [Related]

  • 29. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice.
    Wareing MD, Lyon AB, Lu B, Gerard C, Sarawar SR.
    J Leukoc Biol; 2004 Oct 14; 76(4):886-95. PubMed ID: 15240757
    [Abstract] [Full Text] [Related]

  • 30. Anti-chemokine small molecule drugs: a promising future?
    Proudfoot AE, Power CA, Schwarz MK.
    Expert Opin Investig Drugs; 2010 Mar 14; 19(3):345-55. PubMed ID: 20113217
    [Abstract] [Full Text] [Related]

  • 31. Chemokines and chemokine receptors as therapeutic targets in lupus nephritis.
    Vielhauer V, Anders HJ, Schlöndorff D.
    Semin Nephrol; 2007 Jan 14; 27(1):81-97. PubMed ID: 17336691
    [Abstract] [Full Text] [Related]

  • 32. Identification of 3-(acylamino)azepan-2-ones as stable broad-spectrum chemokine inhibitors resistant to metabolism in vivo.
    Fox DJ, Reckless J, Wilbert SM, Greig I, Warren S, Grainger DJ.
    J Med Chem; 2005 Feb 10; 48(3):867-74. PubMed ID: 15689171
    [Abstract] [Full Text] [Related]

  • 33. Atrial Fibrillation Ablation Increases Inflammation-Chemokine Modulation Suppresses Activation of Leukocytes Isolated after Ablation.
    Al-Ani M, Ambadapadi S, Yaron JR, Zheng D, Fortunel A, Doroton-Guevara M, Liu L, Morshed S, Fricker J, Miles W, McKillop M, Lucas A.
    Cardiovasc Hematol Disord Drug Targets; 2017 Feb 10; 17(3):195-204. PubMed ID: 28925907
    [Abstract] [Full Text] [Related]

  • 34. New strategies for chemokine inhibition and modulation: you take the high road and I'll take the low road.
    McFadden G, Kelvin D.
    Biochem Pharmacol; 1997 Dec 15; 54(12):1271-80. PubMed ID: 9393669
    [Abstract] [Full Text] [Related]

  • 35. Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages.
    Veillard NR, Braunersreuther V, Arnaud C, Burger F, Pelli G, Steffens S, Mach F.
    Atherosclerosis; 2006 Sep 15; 188(1):51-8. PubMed ID: 16321392
    [Abstract] [Full Text] [Related]

  • 36. Chemokine blockers--therapeutics in the making?
    Wells TN, Power CA, Shaw JP, Proudfoot AE.
    Trends Pharmacol Sci; 2006 Jan 15; 27(1):41-7. PubMed ID: 16310864
    [Abstract] [Full Text] [Related]

  • 37. Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease.
    Donnelly LE, Barnes PJ.
    Trends Pharmacol Sci; 2006 Oct 15; 27(10):546-53. PubMed ID: 16911834
    [Abstract] [Full Text] [Related]

  • 38. Identification of oligopeptide sequences which inhibit migration induced by a wide range of chemokines.
    Reckless J, Grainger DJ.
    Biochem J; 1999 Jun 15; 340 ( Pt 3)(Pt 3):803-11. PubMed ID: 10359667
    [Abstract] [Full Text] [Related]

  • 39. Effect of posttranslational processing on the in vitro and in vivo activity of chemokines.
    Mortier A, Gouwy M, Van Damme J, Proost P.
    Exp Cell Res; 2011 Mar 10; 317(5):642-54. PubMed ID: 21146523
    [Abstract] [Full Text] [Related]

  • 40. Nonpeptide ligands that target peptide-activated GPCRs in inflammation.
    Blakeney JS, Fairlie DP.
    Curr Med Chem; 2005 Mar 10; 12(25):3027-42. PubMed ID: 16378503
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.